Artificial Intelligence in Healthcare Market to Reach 187704.75 Million by 2031 | CAGR 41.1% | North America Leads with 43.2% Share | Key Players: Microsoft, Google, IBM, NVIDIA, Philips

Market Overview

The Global Artificial Intelligence in Healthcare Market reached US$ 13,248.65 million in 2022 and is projected to grow substantially, reaching US$ 187,704.75 million by 2031, expanding at a CAGR of 41.1% during 2024-2031. Artificial intelligence (AI) is revolutionizing the healthcare sector by enhancing diagnostic accuracy, optimizing treatment pathways, and streamlining clinical workflows. The technology is being deployed across a wide range of healthcare applications, including medical imaging, predictive analytics, robotic surgery, personalized medicine, virtual health assistants, and patient monitoring systems.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/artificial-intelligence-in-healthcare-market?Juli

The exponential growth of healthcare data from electronic health records (EHRs), wearable devices, and genomics is fueling the adoption of AI-driven solutions to improve decision-making, efficiency, and patient outcomes. Additionally, rising healthcare costs and the global shortage of skilled medical professionals are accelerating demand for AI-based automation and cost-effective healthcare delivery models.

Key Developments:

✅ January 2023 - Microsoft and Epic Systems Partnership
Microsoft and Epic Systems announced a collaboration to integrate generative AI tools into Epic's electronic health record (EHR) software using Azure OpenAI Service, aiming to enhance clinical documentation, administrative workflows, and patient engagement.

✅ April 2023 - Google Cloud Launches MedLM for Healthcare
Google Cloud unveiled MedLM, a suite of medical AI models built on Med-PaLM 2, designed to assist healthcare professionals in data analysis, clinical decision-making, and patient interaction. The solution helps improve diagnostic accuracy and workflow efficiency.

✅ February 1, 2023 - Microsoft Partners with VinBrain
Microsoft Corp. announced a collaboration with VinBrain, a Vietnamese technology company, to advance AI-based healthcare services. The partnership focuses on cross-product validation, data sharing, and R&D initiatives, enhancing diagnostic accuracy and healthcare delivery through AI innovation.

Mergers & Acquisitions:

✅ August 2023 - Siemens Healthineers Acquires SyntheticMR AB
Siemens Healthineers acquired SyntheticMR AB, a Swedish firm specializing in AI-enabled quantitative MRI imaging software, aimed at advancing neuroimaging, oncology, and radiology diagnostics.

✅ October 2023 - Medtronic Acquires AI Startup Odin Technologies
Medtronic plc completed the acquisition of Odin Technologies, an AI company focused on real-time patient monitoring and predictive analytics, strengthening its leadership in connected healthcare and precision medicine.

✅ May 2024 - Philips Acquires Cardiologs Technologies
Royal Philips acquired Cardiologs, a France-based developer of AI-powered electrocardiogram (ECG) analysis and diagnostics software, to enhance its cardiology informatics and digital diagnostics capabilities.

Buy Now & Unlock 360° Market Intelligence:-https://www.datamintelligence.com/buy-now-page?report=artificial-intelligence-in-healthcare-market?Juli

Key Players:

• Microsoft Corporation - Holds a 15% share, leading the market with its Azure AI, Nuance Communications, and cloud-based healthcare solutions, focusing on clinical documentation, patient engagement, and predictive analytics.

• Google LLC - Holds a 13% share, driven by its Google Cloud MedLM and DeepMind Health initiatives, supporting medical imaging, data analysis, and AI-assisted diagnostics through advanced machine learning models.

• Intel Corporation - Holds an 11% share, providing AI hardware accelerators and edge computing platforms that power medical imaging, genomics, and data-intensive healthcare applications.

• IBM Corporation - Holds a 10% share, leveraging its Watson Health and Merative platforms for AI-driven analytics, population health management, and life sciences research.

• NVIDIA Corporation - Holds a 9% share, recognized for its AI computing platforms (Clara, DGX systems) that enable medical imaging, drug discovery, and digital pathology advancements.

• Philips Healthcare - Holds an 8% share, offering AI-enabled diagnostic imaging, patient monitoring, and precision health solutions through its HealthSuite cloud and Care Orchestrator platforms.

• Siemens Healthineers - Holds a 7% share, focusing on AI-powered diagnostic imaging systems, radiology automation, and clinical decision support tools under its AI-Rad Companion and Digital Twin technologies.

• Medtronic plc - Holds a 6% share, emphasizing AI-based patient monitoring, robotic-assisted surgery, and smart medical devices designed to enhance precision medicine and treatment outcomes.

Market Segmentation:

By Product Type
The software segment dominates the market with an estimated 42% share, driven by increasing adoption of AI-based platforms, analytics tools, and machine learning algorithms across healthcare operations. These solutions are widely integrated into clinical decision support, diagnostics, and predictive analytics. The services segment accounts for 32% share, encompassing consulting, integration, and maintenance services required to implement AI solutions within healthcare institutions. The hardware segment represents 22% share, supported by the growing use of AI-enabled medical devices, imaging equipment, and computing infrastructure for faster data processing and diagnostics.

By Technology
The machine learning (ML) segment leads with approximately 35% share, as it forms the backbone of most AI applications, including predictive modeling, diagnostics, and personalized treatment planning. Natural language processing (NLP) holds around 22% share, enabling efficient analysis of unstructured medical data such as clinical notes, EHRs, and research literature. Speech recognition accounts for 15% share, increasingly used in medical transcription, voice-based charting, and patient interaction systems. The disaster recovery and data management segment represents 12%, focusing on secure storage and recovery of critical healthcare information, while other technologies, including computer vision and reinforcement learning, collectively account for 8% share.

By Application
The imaging and diagnostics segment dominates with an estimated 30% share, driven by the increasing use of AI algorithms for image interpretation, early disease detection, and radiology workflow automation. Drug discovery and development holds about 18% share, with pharmaceutical companies leveraging AI to accelerate molecule screening and optimize R&D costs. Precision medicine contributes 14%, focusing on genomics-based treatment personalization. Hospital management and risk analytics collectively hold 12% share, aiding in resource allocation, workflow optimization, and predictive maintenance. Meanwhile, wearables and virtual assistants together represent 10% share, improving patient engagement and remote health monitoring. Healthcare assistant robots and other AI-enabled applications account for the remaining 8% share, supporting elderly care, rehabilitation, and remote diagnostics.

By End-User
The hospitals segment dominates the market with around 45% share, driven by the rising adoption of AI-powered diagnostic imaging systems, electronic health records, and robotic surgery platforms. Pharmaceutical companies hold 25% share, using AI for drug discovery, clinical trials optimization, and predictive analytics. Diagnostic centers represent approximately 14%, leveraging AI-based imaging and automation tools to improve accuracy and efficiency. Other end-users, including research institutes, clinics, and insurance providers, account for the remaining 10% share, as AI continues to enhance healthcare delivery, data management, and patient engagement.

Speak to Our Analyst and Get Customization in the report as per your requirements:-https://www.datamintelligence.com/customize/artificial-intelligence-in-healthcare-market?Juli
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Regional Insights:

North America - 43.2% Share
North America dominates the global AI in healthcare market, led by the United States and Canada, owing to strong technological infrastructure, high healthcare expenditure, and early AI adoption in diagnostics, patient monitoring, and drug development. The presence of major players such as Microsoft, IBM, NVIDIA, GE HealthCare, and Medtronic fuels continuous innovation in AI-driven healthcare solutions. Supportive government initiatives, such as the U.S. FDA's approval of AI-based medical devices and large-scale R&D funding, further bolster regional growth. The increasing integration of AI in telehealth, robotic surgery, and personalized medicine is reinforcing the region's leadership in digital healthcare transformation.

Europe - 26.4% Share
Europe represents a substantial portion of the market, primarily driven by Germany, the UK, France, and the Netherlands, where AI is being rapidly adopted for clinical decision support, predictive analytics, and radiology automation. The European Union's investment in AI4Health and Horizon Europe programs is encouraging startups and research collaborations focused on AI in medical imaging, data privacy, and hospital automation. Key companies such as Siemens Healthineers and Philips are at the forefront of innovation, developing AI-based imaging and diagnostic solutions that enhance workflow efficiency and patient care.

Asia-Pacific - 21.8% Share
Asia-Pacific is the fastest-growing region, propelled by the expanding adoption of AI in diagnostics, wearable health devices, and digital health platforms in countries such as China, Japan, India, and South Korea. Increasing healthcare digitization, government initiatives like China's Healthy AI 2030 Plan, and partnerships between tech firms and healthcare providers are accelerating market expansion. Companies such as VinBrain, Wipro GE Healthcare, and Fujitsu are integrating AI with cloud platforms to enhance accessibility, affordability, and clinical precision. The growing prevalence of chronic diseases and the region's large patient base further contribute to its high growth potential.

Market Dynamics:

Driver:

Rapid Adoption of Advanced AI Technologies
The growth of the AI in healthcare market is primarily driven by the increasing demand for advanced technologies that improve patient outcomes and streamline hospital processes. AI-powered tools can analyze clinical records, research data, and genetic information faster and more accurately than humans, enabling early diagnosis, personalized treatment plans, and predictive analytics. Hospitals and clinics are leveraging AI to automate repetitive tasks such as data entry, record-keeping, and scan interpretation, reducing administrative burdens, improving efficiency, and lowering operational costs.

Rising Incidence of Chronic Diseases
The surge in chronic disorders worldwide has significantly fueled market expansion. AI-driven solutions provide timely insights for early diagnosis, risk assessment, and treatment optimization, helping healthcare providers manage large patient populations effectively. As a result, the demand for AI-enabled diagnostics, patient monitoring systems, and decision-support tools is steadily increasing.

Government Support and Public-Private Funding
Government initiatives and regulatory policies promoting AI adoption in healthcare are creating a conducive environment for market growth. Several nations are increasing research and development (R&D) funding and supporting public-private collaborations to accelerate the development of innovative AI solutions. Investments in medical devices, digital health platforms, and AI-powered medical imaging are opening lucrative opportunities for manufacturers and startups alike.

Technological Advancements and Product Innovation
The development of cutting-edge technologies such as machine learning, natural language processing, and computer vision is further enhancing the capabilities of AI in healthcare. Leading companies are investing heavily in R&D to create next-generation systems, including AI-powered diagnostic imaging, robotic-assisted surgery, clinical decision support, and predictive analytics platforms. Continuous innovation is helping healthcare providers improve patient outcomes, operational efficiency, and resource management, driving market adoption across developed and developing regions.

Opportunities:
Increasing investments in healthcare infrastructure and the need to address imbalances between patient populations and healthcare professionals are creating significant market opportunities. AI solutions can augment medical staff, improve workflow management, and optimize the delivery of healthcare services. With rising expenditures on healthcare modernization and digital transformation, manufacturers and service providers have a fertile environment for introducing innovative AI solutions tailored to evolving healthcare demands.

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots

✅ Market Volatility & Emerging Risks Analysis

✅ Quarterly Industry Report Updated

✅ Live Market & Pricing Trends

✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?Juli

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.